Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 and Older With Asthma

Study Title

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromaxֲ® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Teva Identifier

ABS-AS-301

ClinicalTrials.gov Identifier

NCT01424813

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Placebo MDPI | Drug: Albuterol MDPI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

12/01/2012 - 11/01/2013

Phase

Phase 3

Study Type

Interventional